Manulife (Manufacturers Life Insurance)
CKPT

Manulife (Manufacturers Life Insurance)’s Checkpoint Therapeutics CKPT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,444
Closed -$77K – 3229
2021
Q1 		$77K Sell
2,444
-282
-10% -$9.45K ﹤0.01% 3059
2020
Q4 		$72K Buy
2,726
+49
+2% +$1.24K ﹤0.01% 2968
2020
Q3 		$72K Buy
+2,677
New +$64.3K ﹤0.01% 2860

Other funds holding CKPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CKPT Position: Q2 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Checkpoint Therapeutics (CKPT) in Q2 2021, closing a stake of 2,444 shares — an estimated $77K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CKPT in Q3 2020 and held it in 3 quarters. The position peaked at $77K in Q1 2021. 69 funds tracked by Wall St. Rank hold CKPT as of Q2 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining Checkpoint Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 2,444 Checkpoint Therapeutics shares in Q2 2021, an estimated $77K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Checkpoint Therapeutics in Q3 2020 and held it in 3 quarters.
  • Manulife (Manufacturers Life Insurance)'s Checkpoint Therapeutics position peaked at $77K in Q1 2021.
  • 69 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2021, filed 12 Aug 2021.